Revolution Medicines

Revolution Medicines

Organization

Heard in 5 episodes across 5 shows since Aug 2026

Revolution Medicines is a clinical-stage biopharmaceutical company focused on discovering, developing, and delivering targeted medicines for patients with RAS-addicted cancers. Its pipeline includes RAS pathway inhibitors, including daraxonrasib (RMC-6236).

Episodes

5
across 5 shows

First heard

Aug 2026
Revolution Medicines | PodLume